Life Sciences Partners (LSP), a European firm dedicated to life sciences investments, has launched a new vehicle, LSP Dementia Fund, with a €150m target.
Rabobank is to acquire a 34% stake in the healthcare platform via its Corporate Investments arm
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Intention to list comes four years after the GP acquired the company via its fourth fund
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs